Table 1

Recent methods for the prolonged detection of exogenous AAS by the combination of the implementation of LTMs in screening procedures and the use of sensitive mass spectrometric methods

Exogenous AASLTMsReferences
Metandienone18-nor-17β-hydroxymethyl,17α-methyl-androst-1,4,13-trien-3-one
18-nor-17β-hydroxymethyl,17α-methyl-androst-1,4,13-trien-3-one-sulfate
10, 59, 60
Oxandrolone17β-hydroxymethyl-17α-methyl-18-nor-2-oxa-5α-androsta-13-en-3-one
17α-hydroxymethyl-17β-methyl-18-nor-2-oxa-5α-androsta-13-en-3-one

61
Oxymetholone18-nor-2x, 17β-hydroxymethyl-17α-methyl-5α-androst-13-en-3α-ol
18-nor-17β-hydroxymethyl-17α-2x-methyl-5α-androst-13-en-3-one
7
Desoxymethyltestosterone18-nor-17,17-dimethyl-5α-androst-13-en-2x, 3α-diol7
Dehydrochloromethyltestosterone4-chloro-17-methyl-5β-androstane-3,16,17-triol
4-chloro-17-hydroxymethyl-17-methyl-18-nor-5β-androst-1,13-diene-3-ol
4-chloro-17-hydroxymethyl-17-methyl-18-nor-5β-androst-13-ene-3-ol

6
StanozololStanozolol-N-glucuronide
Stanozolol-O-glucuronide
Epistanozolol-N-glucuronide
3′-Hydroxystanozolol-O-glucuronide
16β-Hydroxystanozolol-O-glucuronide
4β-Hydroxystanozolol-O-glucuronide
24
  • AAS,anabolic androgenic steroids; LTMs, long-term metabolites.